Advertisement Acacia's subsidiary signs licensing agreement with CR Bard - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Acacia’s subsidiary signs licensing agreement with CR Bard

Acacia Research, a developer of patented technologies, has announced that its Thermal Scalpel subsidiary has entered into a licensing agreement with CR Bard covering patents relating to surgical devices.

The agreement resolves litigation that was pending in the US District Court of Texas with respect to certain CR Bard products.

The technology generally relates to surgical devices and methods involving cutting or ablation of tissue in a manner that promotes hemostasis.